Wednesday, July 23, 2014
- Published: July 22, 2014
- DOI: 10.1371/journal.pmed.1001681
Linked Research Article
This Perspective discusses the following new study published in PLOS Medicine:
Musso G, Gambino R, Tabibian JH, Ekstedt M, Kechagias S, et al. (2014) Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis. PLoS Med 11(7): e1001680. doi:10.1371/journal.pmed.1001680
In a systematic review and meta-analysis, Giovanni Musso and colleagues examine the association between non-alcoholic fatty liver disease and chronic kidney disease.
In this week's issue of PLOS Medicine, Musso and colleagues report that two conditions, both occupying increasing amounts of medical attention, may be linked . Their paper demonstrates that non-alcoholic fatty liver disease (NAFLD) is associated with chronic kidney disease (CKD) even after adjustment for major shared risk factors. “Future research,” they write, “should evaluate strategies and interventions to prevent renal disease progression in individuals with NAFLD.” It's a conclusion that is both reasonable and potentially helpful./.../
Monday, July 21, 2014
Copyright © 2014 Elsevier Ltd All rights reserved.
Phage therapy: current research and applications
Jan Borysowski, Ryszard Miedzybrodzki, Andrzej Gorski
Caister Academic Press, 2014394
Under pressure from nature's biological warfare, human beings have long battled against pathogens. Despite extending the average human life expectancy by up to 10 years, antibiotic therapy has repercussions by giving rise to resistant bacteria. InPhage Therapy: current research and applications , the authors give an exciting account of how the humble bacteriophage could become an indispensable source of therapeutics in the future.
Since their discovery in the early 20th ce ...